116 related articles for article (PubMed ID: 2349087)
21. Halogenated isoniazid derivatives VI. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues.
Arena A; Capozza AB; Maccari R; Ottanà R; Vigorita MG
Farmaco; 1996 Jul; 51(7):517-23. PubMed ID: 8765675
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, hydrolytic behavior, and anti-HIV activity of selected acyloxyalkyl esters of trisodium phosphonoformate (foscarnet sodium).
Iyer RP; Boal JH; Phillips LR; Thakker DR; Egan W
J Pharm Sci; 1994 Sep; 83(9):1269-73. PubMed ID: 7530302
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-HIV activity of phosphorothioate antisense DNA containing C-5 polyamine substituted 2'-deoxyuridine and/or acridine residues.
Shinozuka K; Okamoto T; Matsukura M; Sawai H
Nucleic Acids Symp Ser; 1997; (37):215-6. PubMed ID: 9586076
[TBL] [Abstract][Full Text] [Related]
24. Novel route to oligo(deoxyribonucleoside phosphorothioates). Stereocontrolled synthesis of P-chiral oligo(deoxyribonucleoside phosphorothioates).
Stec WJ; Grajkowski A; Koziolkiewicz M; Uznanski B
Nucleic Acids Res; 1991 Nov; 19(21):5883-8. PubMed ID: 1945876
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and nuclease susceptibility of alpha-oligodeoxyribonucleotide phosphorothioate.
Shinozuka K; Morita T; Sawai H
Nucleic Acids Symp Ser; 1991; (25):101-2. PubMed ID: 1842039
[TBL] [Abstract][Full Text] [Related]
26. A new candidate for an anti-HIV-1 agent: modified cyclodextrin sulfate (mCDS71).
Moriya T; Saito K; Kurita H; Matsumoto K; Otake T; Mori H; Morimoto M; Ueba N; Kunita N
J Med Chem; 1993 May; 36(11):1674-7. PubMed ID: 8496933
[No Abstract] [Full Text] [Related]
27. Backbone modified oligodeoxynucleotides: stereoselective synthesis of methylphosphonates and HIV inhibitory capacity of phosphorothioates.
Engels JW; Daum T; Frauendorf A; Lüking S; Mag M; Müller WE; Muth J; Rosmanitz P
Nucleic Acids Symp Ser; 1991; (24):83-6. PubMed ID: 1841388
[TBL] [Abstract][Full Text] [Related]
28. Novel method of synthesis of oligo(deoxyribonucleoside phosphorothioates).
Stec WJ
Nucleic Acids Symp Ser; 1991; (25):171-2. PubMed ID: 1842071
[TBL] [Abstract][Full Text] [Related]
29. Antiviral amphipathic oligo- and polyribonucleotides: analogue development and biological studies.
Hyde RM; Broom AD; Buckheit RW
J Med Chem; 2003 May; 46(10):1878-85. PubMed ID: 12723951
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effect of the crude extract from a seaweed of Dygenea simplex C. Agardh on the in vitro cytopathic activity of HIV-1 and it's antigen production.
Sekine H; Ohonuki N; Sadamasu K; Monma K; Kudoh Y; Nakamura H; Okada Y; Okuyama T
Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1580-4. PubMed ID: 7586085
[TBL] [Abstract][Full Text] [Related]
31. Solid phase synthesis of oligodeoxyribonucleoside phosphorodithioates from thiophosphoramidites.
Bjergårde K; Dahl O
Nucleic Acids Res; 1991 Nov; 19(21):5843-50. PubMed ID: 1945874
[TBL] [Abstract][Full Text] [Related]
32. Anti-human immunodeficiency virus type 1 activity of phosphorothioate analogs of oligodeoxynucleotides: penetration and localization of oligodeoxynucleotides in HIV-1-infected MOLT-4 cells.
Nakashima H; Shoji Y; Kim SG; Shimada J; Mizushima Y; Ito M; Yamamoto N; Takaku H
Nucleic Acids Res; 1994 Nov; 22(23):5004-10. PubMed ID: 7528375
[TBL] [Abstract][Full Text] [Related]
33. 1-(3-cyano-2,3-dideoxy-beta-D-erythro-pentofuranosyl)thymine (cyanothymidine): synthesis and antiviral evaluation against human immunodeficiency virus.
Greengrass CW; Hoople DW; Street SD; Hamilton F; Marriott MS; Bordner J; Dalgleish AG; Mitsuya H; Broder S
J Med Chem; 1989 Mar; 32(3):618-22. PubMed ID: 2918509
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anti-HIV-1 activity of N-hydroxy-N1-aminoguanidines.
Doubell PC; Oliver DW
Arzneimittelforschung; 1992 Jan; 42(1):65-9. PubMed ID: 1586383
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anti-HIV activity of 10,11-dihydropyrrolo [1,2-b][1,2,5]benzothiadiazepine-11-acetic acid 5,5-dioxide derivatives and related compounds.
Silvestri R; Artico M; Pagnozzi E; Stefancich G; Massa S; La Colla P; Loi AG; Spiga MG; Corrias S; Lichino D
Farmaco; 1996 Jun; 51(6):425-30. PubMed ID: 8766226
[TBL] [Abstract][Full Text] [Related]
36. Short, terminally phosphorylated oligoriboguanylic acids effectively inhibit cytopathicity caused by human immunodeficiency virus.
Fujihashi T; Sakata T; Kaji A; Kaji H
Biochem Biophys Res Commun; 1994 Sep; 203(2):1244-50. PubMed ID: 7916572
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.
Sarin PS; Agrawal S; Civeira MP; Goodchild J; Ikeuchi T; Zamecnik PC
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7448-51. PubMed ID: 3174646
[TBL] [Abstract][Full Text] [Related]
38. Phosphorothioate oligodeoxynucleotides are potent sequence nonspecific inhibitors of de novo infection by HIV.
Stein CA; Matsukura M; Subasinghe C; Broder S; Cohen JS
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):639-46. PubMed ID: 2482061
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HIV activity of new urea and nitrosourea derivatives of diamino acids.
Dulude H; Salvador R; Gallant G
Bioorg Med Chem; 1995 Feb; 3(2):151-60. PubMed ID: 7796048
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiviral activity of 3'-heterocyclic substituted 3'-deoxythymidines.
Wigerinck P; Van Aerschot A; Janssen G; Claes P; Balzarini J; De Clercq E; Herdewijn P
J Med Chem; 1990 Feb; 33(2):868-73. PubMed ID: 2299650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
